CBMG and GE Healthcare Life Sciences Chi… – Genetic Engineering & Biotechnology News
|
CBMG and GE Healthcare Life Sciences Chi…
Genetic Engineering & Biotechnology News Cellular Biiomedicine Group and GE Healthcare Life Sciences China agreed to a strategic research collaboration to co-develop certain high-quality industrial control processes in Chimeric Antigen Receptor T-cell (CAR-T) and stem cell manufacturing. |
|
U.S. Stem Cell, Inc.’s MARVEL Phase II/III Trial Receives Reactivation Status with the FDA
Yahoo Finance SUNRISE, FL / ACCESSWIRE / April 10, 2017 / U.S. Stem Cell, Inc. (USCC) (USRM), a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therapies for human and animal patients, has received reactivation … |
Genetic Literacy Project |
Questions abound on synthetic biology: Is it creating ‘new life’ or just part of biotechnology’s toolkit?
Genetic Literacy Project My guess is that both the methods and the technology of synthetic biology — and here I’m thinking particularly of DNA synthesis — will continue to become more common, less remarked upon, and just part of the toolkit of biotechnology and bioengineering. |
Civil Eats |
Monsanto’s Driverless Car: Is CRISPR Gene Editing Driving Seed Consolidation?
Civil Eats And it’s just one of many indications that CRISPR/Cas9 and other next-generation gene editing technologies will likely be at the forefront of the seed industry in the years ahead. Some even see gene editing, which is said to be simpler, less expensive … |